Initial public offerings scheduled to debut next week - Quincy Herald-Whig | Illinois & Missouri News, Sports

Initial public offerings scheduled to debut next week

Posted: Updated:

NEW YORK (AP) - The following is a list of initial public offerings planned for the coming week. Sources include Renaissance Capital, Greenwich, CT (www.renaissancecapital.com) and SEC filings.

Week of July 14:

CareDx Inc. - Brisbane, Calif., 3.1 million shares, priced $15 to $17 managed by Piper Jaffray and Leerink Partners. Proposed Nasdaq symbol CDNA. Business: Sells molecular diagnostic tests to monitor heart transplants.

Globant S.A. - Luxembourg, 6.3 million shares, priced $11 to $13, managed by J.P. Morgan, Citigroup, and Credit Suisse. Proposed NYSE symbol GLOB. Business: Provider of mobile, website, cloud, and big data IT solutions, operating primarily out of Buenos Aires, Argentina.

iRadimed Corp. - Winter Springs, Fla., 1.75 million shares, priced $5 to $6, managed by Roth Capital. Proposed Nasdaq Capital Market symbol IRMD. Business: Provider of non-magnetic intravenous infusion pump systems that are safe for use during magnetic resonance imaging procedures.

Medical Transcription Billing Corp. - Somerset, N.J., 3 million shares, priced $9 to $11, managed by Chardan Capital Markets, Aegis Capital, and Summer Street Research. Proposed Nasdaq symbol MTBC. Business: Provides a software as a service platform for ambulatory care facilities. Originally scheduled to price week of July 7.

Pfenex Inc. - San Diego, 5 million shares, priced $12 to $14, managed by William Blair and JMP Securities. Proposed NYSE symbol PFNX. Business: Clinical-stage biotech developing difficult to manufacture and high-value proteins initially focued on biosimilar therapeutics.

Roka BioScience Inc. - Warren, N.J., 5 million shares, priced $14 to $16, managed by BofA Merrill Lynch, Leerink Partners, and Cowen & Co. Proposed Nasdaq symbol ROKA. Business: Develops food safety testing equipment that uses molecular diagnostics.

Sage Therapeutics Inc. - Cambridge, Mass., 4 million shares, priced $14 to $16, managed by J.P. Morgan and Goldman Sachs. Proposed Nasdaq symbol SAGE. Business: Biotech developing treatments for life-threatening seizures.

TerraForm Power Inc. - Beltsville, Mass., 20.1 million shares, priced $19 to $21, managed by Goldman Sachs, Barclays, and Citigroup. Proposed Nasdaq symbol TERP. Business: Solar energy yieldco spun out of SunEdison.

Trupanion Inc. - Seattle, 7.1 million shares, priced $13 to $15, managed by RBC Capital Markets, Barclays, and Stifel. Proposed NYSE symbol TRUP. Business: Provides medical insurance covering cats and dogs in North America.

TubeMogul Inc. - Emeryville, Calif., 6.3 million shares, priced $11 to $13, managed by BofA Merrill Lynch, Citigroup, and RBC Capital Markets. Proposed Nasdaq symbol TUBE. Business: Provides a programmatic digital video ad buying platform for brand advertisers.

Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and Quincy Herald-Whig. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service and Mobile Privacy Policy & Terms of Service.